This article announces the filing of a Form 8K by Stabilis Solutions Inc. for August 11. It's a brief financial markets news item published by Investing.com, likely indicating a significant event or disclosure by the company.
Stabilis Solutions, Inc. (NASDAQ:SLNG) announced that its shareholders elected six directors and ratified CohnReznick L.L.P. as its independent auditor for fiscal year 2026 during the company's annual meeting. The elected directors include J. Casey Crenshaw, Benjamin J. Broussard, Stacey B. Crenshaw, Edward L. Kuntz, …
Curaleaf Holdings Inc. announced its intention to launch a takeover bid for Edmonton-based Aurora Cannabis Inc. after private negotiation attempts failed. Curaleaf plans to offer US$4.00 per share plus US$0.75 cash for each Aurora share, a proposal that analysts believe undervalues Aurora's long-term potential. …
UBS has upgraded Jabil stock to Buy from Neutral, setting a price target of $430.00, citing a multiyear growth cycle driven by AI investments from major tech companies like Amazon, Meta, and Google, alongside rising healthcare demand and automation. The firm anticipates Jabil's revenue …
Athira Pharma, Inc. (NASDAQ:LONA) has received a "Moderate Buy" consensus rating from analysts, with four out of six recommending a buy. The average 12-month price target is set at $16.00, significantly higher than its current share price of $7.68. Despite being a high-risk, clinical-stage …
This article first appeared on GuruFocus. Release Date: August 03, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Stabilus SE (WBO:STA2) successfully completed the sale of Fabrica and TECH products, generating an enterprise …
Jabil Inc. (JBL) stock fell by 1.35% on Monday, closing at $336.63, while the broader market also experienced a downturn. The S&P 500 Index decreased by 0.06% and the Dow Jones Industrial Average dropped by 0.11%. This marked the second consecutive day of losses …
Sabine Royalty Trust (SBR) recently reported stronger oil and gas production for August 2026, leading to a higher cash distribution of US$0.619430 per unit. This improved output and increased payout reinforce the income-focused investment narrative, though the stock's current trading price is still considered …
PDT Partners has disclosed a 0.79% net short position in Abivax shares, which is just below the 1% threshold typically considered for major short stakes. This information was generated by Public Technologies (PUBT) using AI, based on content originally published by Abivax SA on …
Aurora Cannabis Inc. (ACB) shares fell by 3.34% to $2.89 on Monday, underperforming the broader market. The NASDAQ Composite Index and Dow Jones Industrial Average also experienced declines, falling 0.32% and 0.11% respectively. This drop ended a three-day winning streak for Aurora Cannabis Inc.
Aurora Cannabis shareholders approved all governance resolutions at their August 7, 2026, annual general meeting, including fixing the board size at five directors, reappointing Ernst & Young, and endorsing executive compensation. Director nominees, including CEO Miguel Martin, received strong majority support, with votes generally …
Aurora Cannabis Inc. announced the voting results from its Annual General Meeting of Shareholders, held virtually on August 7. The company's shares were trading down at $4.09. The article also briefly mentions other investment-related topics such as gold prices and quantum computing.
Key Takeaways; Cannabis Sector Canopy Growth Posted 13% Revenue Growth as Losses Narrowed Sharply in Q1 FY2027 Aurora Cannabis Narrowed Q1 Loss as International Medical Cannabis Growth Gained Ground Cronos Group Reported Record Q2 Revenue as Profitability and EBITDA Surged Key Takeaways; Psychedelic Sector …
Raises its 2026 Revenue Target to $355m, its Second Increase This Year Highlights Updated revenue target reflects growth of 111% compared with 2025, on continued demand for the Company's systems Another quarter of accelerated growth – revenue of $88.2m, up 138% year-over-year Gross margin …
Parabilis Medicines (PBLS) is a clinical-stage biopharmaceutical company with a market cap of US$4.6 billion. The company recently completed a record-breaking biotech IPO, raising substantial capital to fund a pivotal Phase 3 cancer therapy trial and expand its Helicon platform. Despite significant capital raises …
This article provides the current stock price, news, and historical data for Trulieve Cannabis Corp. (TRLV). It highlights the company's recent Q2 earnings call, expansion plans in Georgia and Texas, and its June listing on the New York Stock Exchange. The news section also …
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.